IGF LR3

IGF LR3, also known as Insulin-Like Growth Factor 1 Long Arg3, is a synthetic peptide analog of IGF-1 that has been studied for its potential role in cellular growth signaling, protein synthesis pathways, and metabolic research. This product is provided strictly for academic, laboratory, and research-use-only applications.

Research Context

IGF LR3 is a modified form of insulin-like growth factor 1, engineered with an arginine substitution at position 3 and an extended amino acid sequence. These structural modifications have made it a subject of interest in experimental studies examining receptor interaction, cellular proliferation, and anabolic signaling pathways.

Research involving IGF LR3 has primarily focused on its interaction with IGF-1 receptors and its potential influence on pathways associated with cellular repair, tissue growth models, glucose metabolism, and protein regulation. Its extended structure has also been studied for differences in biological activity when compared with native IGF-1 in controlled laboratory settings.

Research Overview

IGF LR3 continues to be investigated in preclinical and laboratory research for its potential effects on cellular signaling, metabolic activity, and growth-related pathways. Studies have explored its role in activating intracellular mechanisms connected to protein synthesis, cell survival, and tissue regeneration models.

Experimental research has also examined IGF LR3 in relation to insulin-like signaling, glucose uptake, and muscle cell differentiation. These studies remain limited to controlled research environments and do not establish any approved therapeutic, cosmetic, or diagnostic use.

Key Research Focus Areas

• Cellular Growth Signaling: Investigation of IGF LR3’s interaction with IGF-1 receptor pathways involved in cell growth, survival, and differentiation.
• Protein Synthesis Research: Study of its potential influence on anabolic signaling pathways associated with protein regulation and cellular repair models.
• Metabolic Function: Examination of IGF LR3’s role in glucose uptake, insulin-like signaling, and metabolic pathway regulation in experimental systems.
• Tissue Regeneration Models: Exploration of its potential relevance in preclinical models related to tissue growth, repair, and recovery mechanisms.

Regulatory and Safety Considerations

IGF LR3 is intended exclusively for use in qualified research environments. Proper laboratory procedures should be followed for handling, storage, documentation, and disposal. Researchers must comply with all applicable local, state, and federal regulations related to peptide research and laboratory safety.

This product is not approved for medical, therapeutic, cosmetic, veterinary, or diagnostic use. No claims are made regarding efficacy, treatment, prevention, or safety in humans or animals. Research should only be conducted by trained personnel using appropriate laboratory protocols and institutional guidelines.

For research use only. Not for human or animal consumption.